In addition to these biomarkers, which are also present in CSF, changes in the expression of the RTN1 protein in the blood, related to the production of Aβ and BACE1 enzyme activity, may affect the pathological process of AD [174]. The gene discussed is RTN1; the disease is Alzheimer disease.